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High blood pressureThe present study was designed to develop an animal model of hypertension and cardiac hypertrophy
associated with obesity in female rats. Furthermore, we studied the involvement of the natriuretic peptide
system in the mechanisms of these conditions. Obesity was induced in Wistar rats by a high fat diet and
ovariectomy. The rats were divided into four groups: ovariectomized or sham-operated with high-fat diet and
ovariectomized or sham-operated with control diet. After 24 weeks of diet, rats were killed, and their tissues
were removed. Cardiac atrial natriuretic peptide (ANP), clearance receptor (NPr-C) gene expression was
determined by PCR. ANP concentrations were measured in plasma. Ovariectomized fat-fed rats (OF) showed
increased body weight, visceral fat depot and blood pressure and decreased sodium excretion compared to
other groups. Also, these rats showed higher heart-to-body weight and cell diameters of ventricular
cardiomyocytes and lower cardiac ANP mRNA and plasma ANP than the control group. The adipocyte and
renal NPr-C mRNA of OF rats were higher than the control group. These data showed that combined
ovariectomy and high fat diet elicited obesity, hypertension and cardiac hypertrophy. These results suggest
that the impairment of the natriuretic peptide system may be one of the mechanisms involved not only in
development of hypertension but also in cardiac hypertrophy associated with obesity in ovariectomized rats.: +55 77 3424 0102.
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Obesity is a major challenge for basic scientiﬁc and clinical research
because it represents an important risk for serious diet-related chronic
diseases including cardiovascular disease. Among other factors, obesity is
an important contributor to hypertension in humans, and it is associated
with salt retention [1], especially in postmenopausal women. Data from
theFraminghamHeart Study suggest that 65%of essential hypertension in
women can be directly attributed to obesity [2]. Cardiovascular diseases
are the leading cause of death in women, and the vast majority of them
occur in postmenopausal women [3]. Also, postmenopausal women are
characterized by higher abdominal fatmass accumulation comparedwith
premenopausal women [4].
Hypertension commonly leads to ventricular hypertrophy, which is a
major risk factor for the development of heart failure [5]. Clinical and
experimental studies have established that sex inﬂuences the patterns ofventricular hypertrophy [6]. In fact, the incidence of hypertrophy in
postmenopausal women exceeds that of age-matchedmen [7] and it can
be reversed by hormone replacement therapy [8], suggesting that
estrogen may oppose developmental events in the cardiomyocyte that
generate hypertrophy. Themechanisms that link obesity with high blood
pressure, cardiac hypertrophy and postmenopausal status have not been
fully elucidated.Despitewell-establishedmodelsofhypertension, suitable
animal models to study postmenopausal hypertension and myocardial
hypertrophy associated with obesity are lacking. The ideal model would
not onlyhave the features of humanhypertensionbut also allowthe study
of changes in cardiovascular function that occur with weight gain and
estrogen loss. The diet-induced obese animal models appear to be the
most relevant with regard to human obesity. Some studies have revealed
that high-fat diets promote hypertension [5] and activation of the
systemic renin–angiotensin system [9]. Unfortunately, these studies
utilized only male animals and most studies using female animals failed
to show obesity hypertension and cardiac hypertrophy induced by high-
fat diet [10–12].
It has been suggested that renal sodium retention and increased
activation of the sympathetic systemmay contribute to the development
Table 1
Control and high-fat diet composition.
Control diet High-fat diet
Metabolizable energy (Mcal kg−1) 3.77 4.94
Energy as proteins, % 20.8 14.4
Energy as carbohydrate, % 68.6 31.2
Energy as fat, % 10.6 54.4
Ingredient, %
Cornstarch 37.38 13.88
Soybean meal 30.50 30.50
Dextrinized cornstarch 10.00 10.00
Sucrose 6.00 6.00
GP (soybean oil 7.50 7.50
Bovine lard 0.50 24.00
Fiber 3.17 3.17
Mineral mix (AIN-93M-MX)a 3.50 3.50
Vitamin mix (AIN-93-VX)a 1.00 1.00
L-cystine 0.30 0.30
Choline bitartrate (41.1% choline) 0.15 0.15
Tert-butylhydroquinone 0.0014 0.0028
Sodium (mg kg−1) 1019.0 1019.0
a Described in Reeves et al., 1993 [22].
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natriuretic peptide system, have also been suggested to cause obesity-
related hypertension. Some authors hypothesized that obese individuals
may have an impaired natriuretic response [14,15]. Atrial natriuretic
peptide (ANP) is a hormone mainly secreted by atrial cardiomyocytes in
response to mechanical stretch [16]. ANP is involved in the regulation of
blood pressure and blood volume and markedly stimulates diuresis and
natriuresis [17]. In experimental models caloric deprivation through
fasting decreases NPr-C, the receptor involved in clearance of the peptide;
and consequently results in increased circulating ANP levels [18]. In obese
men, during weight reduction, the decrease in blood pressure is
accompanied by an increase in natriuresis and correlates to down-
regulation of adipocyte NPr-C [19], suggesting that subsequently elevated
ANP can contribute to blood pressure reduction in obese subjects.
Besides its role in regulation of blood pressure and blood volume,
ANP is a direct moderator of cellular growth, and it plays an important
autocrine role in the heart as an inhibitor of cardiac hypertrophy [20].
However, impaired expression of the ANP gene results in cardiac
hypertrophy [21]. The purpose of the present study was to develop an
animal model of hypertension and cardiac hypertrophy associated
with obesity induced by high fat diet and ovariectomy. Furthermore,
we tested the hypothesis that the impairment of natriuretic peptide
system may contribute not only to development of obesity hyperten-
sion but also to cardiac hypertrophy in ovariectomized fat-fed rats.
2. Methods
2.1. Animals
The study was approved by the “Ethics Committee in Animal
Experimentation of the Estadual University of Feira de Santana” and
carriedout according to the recommendations of theNational Institutes of
Health Guide for the Care and Use of Laboratory Animals. Female Wistar
rats weighting 150–200 g were obtained from ICS-UFBA (Salvador, BA,
Brazil). The animals (6 per cage) were maintained under controlled light
and temperature conditions (lights on from 07:00 to 19:00 h, 23±3 °C)
and had free access to tap water and a standard rat chow (AIN 93;
Pragsoluções, Brazil). The animalswere ovariectomizedor sham-operated
using ketamine 50 mg/kg and xylazine 5 mg/kg (im). The animals
received a prophylactic antibiotic injection (pentabiotic, Fontoura-
Wyeth, 0.4 ml/animal/im).
2.2. Diet protocol
After 1-week acclimation, rats were randomly divided into four
groups: ovariectomized with high-fat diet (OF, n=6), sham-operated
withhigh-fat diet (SF,n=6), ovariectomizedwith control diet (OC,n=6)
or sham-operatedwith control diet as the control group (SC, n=6). Diets
were manufactured by Pragsoluções (São Paulo, SP, Brazil). The
composition of the diets [22] is listed on Table 1. All rats weremaintained
on their diet for 24 weeks.
2.3. Experimental procedures
At the end of everyweek in the entire study period, bodyweight and
blood pressure were measured. At 0, 6, 12 and 24 weeks, the rats were
placed in metabolic cages to collect 24-h urine samples and measure
food intake over four days. Blood and urine samples were collected to
quantify sodium and creatinine levels. At the end of the study, rats were
sacriﬁced by decapitation and blood was collected in tubes containing
10−5 mol/L EDTA 10−5, 10−5 mol/L phenylmethylsulfonyl ﬂuoride and
0.5×10−5 mol/L Pepstatin A (all purchased from SigmaChemical Co. St.
Louis, MO, USA). Heart, uterus, kidneys and fat depots (mesenteric and
parametrial) were removed, weighed, and snap frozen in liquid
nitrogen.2.4. Systolic, diastolic and mean blood pressure and heart rate
The onset and development of hypertension were assessed with
the tail-cuff method using a LE5001 Electro-Sphygmomanometer
(Panlab, Barcelona, Spain) after the rats were warmed at 35 °C for
5 min. Heart rate and mean blood pressure were measured under
conscious conditions at the end of every week of the diet. The average
of six pressure readings was recorded for each measurement.
2.5. Radioimmunoassay
The plasma ANP levels were determined by radioimmunoassay
as previously described [23]. ANP antibody was kindly donated by
Dr. Jolanta Gutkowska (CHUM-Université de Montreal, Montreal,
Canada).
2.6. Measurement of cardiomyocyte diameter and ﬁbrosis
Hearts were placed in 10% formaldehyde and embedded in
parafﬁn. Transverse sections (4 μm thick) of the ventricles were
stained with hematoxylin and eosin stain or Masson's trichrome. The
images were captured using Adobe Photoshop 4.0 imaging software
followed by analysis using Image Pro Plus 4.1 imaging software
(Media Cybernetics, Silver Spring, MD). Approximately 50 cardio-
myocytes were selected from the ﬁve to seven images captured at
different sites, and one average value of the cross-sectional diameter
for the heart was calculated for each animal. Also, for each animal, one
average value for ﬁbrosis of the heart was calculated.
2.7. Renal function studies
The rats were placed in metabolic cages during four days to collect
24-h urine and blood samples, which were used to measure levels of
creatinine and sodium. Plasma creatinine was measured by the Jaffé
method [24], whereas the levels of sodium were measured using a
ﬂame photometer (Mod. 910, Analyser, SP, Brazil). Glomerular
ﬁltration rate (GFR) was estimated by calculating creatinine
clearance.
2.8. RNA extraction and PCR
RNA from heart, adipose tissue and kidney was extracted using
Trizol reagent following the supplier's protocol. Using MMLV reverse
transcriptase under standard conditions in a 20 μl reaction, 2 μg of
RNAwas reverse transcribed. For amplifying ANP the oligonucleotides
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were used as forward and reverse primers [25], respectively. The
forward and reverse primers used for amplifying NPr-C were
5′-GCGAAGCCTGAGTTTGAGAA-3′ and 5′-ATACCGATCCCCATTAG-
CAT-3′ [25]. Primers were manufactured by Prodimol Biotechnology
(Belo Horizonte, Brazil). The PCR ampliﬁcations were performed at
95 °C, 5 min followed by 29 cycles at 94 °C, 30 s; 60 °C, 45 s; and 72 °C,
1 min for ANP, and 31 cycles at 94 °C, 30 s; 58 °C, 45 s; and 72 °C,
1 min for NPr-C. Final extension was for 10 min. All reaction products
were separated on a 1.5% agarose gel and stained with ethidium
bromide. β-Actin was ampliﬁed as an internal control in each PCR test
using speciﬁc primers [26] to provide a semi-quantitative assessment.
The result is an average of three PCR reactions.months on diet
Fig. 1. Body weights of sham-operated control diet-fed (SC), sham-operated fat-fed
(SF), ovariectomized control diet-fed (OC) and ovariectomized fat-fed (OF) rats during
six months of diet. *pb0.05 compared to SC rats.2.9. Statistical analysis
Data were expressed as mean±SEM and analyzed using GraphPad
software. Data were compared using one-way ANOVA followed by
Newman–Keuls post-hoc test or two-way ANOVA followed by
Bonferroni post-test. Correlations were calculated using two-tailed
Pearson's correlation coefﬁcients. Data was considered statistically
signiﬁcant at the pb0.05 level.3. Results
3.1. Body weight, caloric intake and organ mass
The body weights (BW) for SC, SF, OC and OF rats were measured
weekly. Initial mean BWs of the four groups did not differ signiﬁcantly
(Table 2). Ovariectomized fat-fed rats had signiﬁcantly higher BW
than control rats starting at month 2 and remaining higher
throughout the 16-week dietary period (Fig. 1). At month 5, the
BWs of SF and OC rats were signiﬁcantly greater than those of control
rats (Fig. 1). Ovariectomy or high fat diet enhanced more than 3-fold
the body weight gain compared to the control rats. A combination of
both ovariectomy and high fat diet, increased the body weight gain by
almost 6-fold compared to the control rats (Table 2).
At the end of 24 weeks of the diet, the sum of visceral fat pads was
greater in all groups compared with control rats (Table 2). There was
no difference in feed consumption between the groups (data not
shown), but due to greater caloric density of the high-fat diet, caloric
intake was higher for high-fat diet groups compared with the
standard diet groups (Table 2).
As expected, the uterine weight decreased in both ovariectomized
groups (0.48±0.05 and 0.30±0.05 versus 2.28±0.33 mg/g BW of SC,
pb0.05), due to lack of ovarian hormones. There were no differences
in kidney weights among the four groups (data not shown).Table 2
Comparison of weight gain, visceral fat weights, heart weights, caloric intake and fractional
the mean±SEM, n: 4 or 6 rats/group.
Variable Control diet
Sham-operated Ov
Initial body weight, g 220±16 2
Final body weight, g 270±6 3
Total weight gain, g 50±10 1
Visceral fat weight, g 14.2±3.7 33
caloric intake, kcal/day 58.8±3.3 66
Heart, g 2.2±0.14 2.
Fractional sodium excretion, % 0.383±0.07 0.4
BW: body weight.
⁎ pb0.05 vs. control rats (sham-operated control diet-fed rats).
† pb0.05 vs. (sham-operated fat-fed rats).
†† pb0.05 vs. (ovariectomized control diet-fed rats).3.2. Blood pressure and heart rate
The initial mean blood pressure was 91±3 mmHg for all of the
rats used in the experiment. After ﬁve months of the diet, the mean
blood pressure of OF rats was 112±3 mmHg, which was signiﬁcantly
higher than that of either OC (92±3 mmHg), SF (94±3 mmHg) or
control SC (92±4 mmHg) groups (Fig. 2A). The heart rate was not
signiﬁcantly different among groups (data not shown). A direct
correlation was observed between body weight and mean blood
pressure (p=0.0062) (Fig. 2B).
3.3. Renal function and natriuretic peptide system
Plasma creatinine, urine ﬂow and GFR did not differ between
experimental groups (datanot shown). The fractional excretionof sodium
(FENa+) decreased in ovariectomized fat-fed rats compared with other
groups (Table 2). An inverse correlation was observed between mean
blood pressure and FENa+ in ovariectomized rats (r=−0.689,
p=0.003).
For testing the hypothesis that the increase of adipose tissue mass
can lead to an ampliﬁed expression of NPr-C, we compared the status
of gene expression by PCR. Ovariectomized rats presented higher
NPr-C mRNA in visceral fat depot than control rats. No change was
observed in adipocyte NPr-C mRNA in sham-operated control diet-
fed group (Fig. 4). An inverse correlation was observed between
adipocyte NPr-C gene expression and FENa+ in ovariectomized rats
(r=−0.775, p=0.024). Ovariectomized fat-fed rats presented
higher renal NPr-C gene expression than the control rats. No change
was observed in renal NPr-C gene expression in SF and OC groups
(Fig. 4). Plasma ANP level of ovariectomized fat-fed rats were lowersodium excretion between control diet and high-fat diet female Wistar rats. Values are
High fat diet
ariectomized Sham-operated Ovariectomized
39±10 221±3 235±2
98±25⁎ 420±9⁎ 520±14⁎ †
59±13⁎ 199±6⁎ 290±11⁎ †
.6±3.2⁎ 36.3±6.8⁎ 47.7±3.3⁎ †
.8±5.3†† 83.3±16.0⁎ 83.8±11.3⁎
27±0.23 2.70±0.08 3.17±0.12⁎
20±0.049 0.400±0.07 0.178±0.015⁎ †
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Fig. 2.Mean blood pressure measured by the tail-cuff method in sham-operated control
diet-fed (SC), sham-operated fat-fed (SF), ovariectomized control diet-fed (OC) and
ovariectomized fat-fed (OF) rats during six months of diet. (B) Correlation between
mean blood pressure (MBP) and body weight of SC, SF, OC and OF after six months of
diet. *pb0.05 compared to SC rats.
Fig. 4. Adipocyte and renal expression of NPr-C gene. The expression of this gene was
examined at the mRNA levels in visceral adipose tissue and renal tissue in sham-operated
control diet-fed (SC), sham-operated fat-fed (SF), ovariectomized control diet-fed (OC) and
ovariectomized fat-fed rats (OF). Top panel: Representative ethidiumbromide visualization of
RT-PCR products. Bottom panel:NPr-C signal intensities were normalized to β-actin. *pb0.05
compared to SC rats, **pb0.05 compared to ovariectomized control diet-fed rats.
152 E.N. de Andrade et al. / Regulatory Peptides 167 (2011) 149–155than all other groups (Fig. 3). Also, the ANP gene expression in both
right and left atria of ovariectomized and fat-fed rats was lower than
in the control group (Fig. 5).
3.4. Cardiac and cardiomyocyte morphology
The relative heart weight of ovariectomized and fat-fed rats was
signiﬁcantly increased compared with the control group (Table 1).200
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Fig. 3. Plasma ANP levels of sham-operated control diet-fed (SC), sham-operated fat-fed
(SF), ovariectomized control diet-fed (OC) and ovariectomized fat-fed rats (OF) after
six months of diet. *pb0.05 compared to SC.Morphological and histological analysis of hearts revealed a concen-
tric ventricular hypertrophy along with increased cardiomyocyte
diameter in the ovariectomized fat-fed rats compared to the other
groups (Fig. 6B, C) In Fig. 6A, representative mid-region transverse
sections show that cardiac enlargement in the OF rats was associated
with reduced chamber lumen and increased wall thickness, indicative
of concentric hypertrophy. In addition, ventricular expression of ANP
mRNA was found to be decreased in ovariectomized fat-fed rats
(Fig. 5). An inverse correlationwas observed between ventricular ANP
gene expression and heart weight in ovariectomized rats (r=−0.832,Fig. 5. Expression of ANP gene in heart. The expression of this gene was examined at the
mRNA levels in right and left atrium and ventricle from sham-operated control diet-fed (SC),
sham-operated fat-fed (SF), ovariectomized control diet-fed (OC) and ovariectomized fat-fed
rats (OF). Top panel: Representative ethidium bromide visualization of RT-PCR products.
Bottompanel:ANP signal intensitieswere normalized toβ-actin.*pb0.05 compared to SC rats.
Fig. 6.Morphological assessment of cardiac hypertrophy in ovariectomized fat-fed rats (OF).
(A) Hematoxylin and eosin-stained whole heart mid-region cross sections of representative
sham-operated control diet (SC) sham-operated fat-fed (SF), ovariectomized control diet-fed
(OC)andOF rats. (B)Cardiomyocytediameterswereestimatedbyquantitativemorphometry
of hematoxylin and eosin-stained ventricular sections of SC, SF, OC and OF rats. Black lines
indicate cardiomyocyte diameters in the region of the cell nucleus, which was signiﬁcantly
increased in OF hearts. (C) Bar graphs of cardiomyocyte diameter of SC, SF, OC and OF rats
(n=6 hearts/group, *pb0.05 vs. SC rats).
153E.N. de Andrade et al. / Regulatory Peptides 167 (2011) 149–155p=0.0042). The degree of interstitial and perivascular ﬁbrosis, as
assessed by Masson's trichrome staining, was not different in obese
rats compared to controls (data not shown).5. Discussion
Female Wistar rats, ovariectomized and fed a diet with high-fat
content, were used in a model of obesity-related hypertension similar
to that observed in menopause. We have examined the effects of
ovariectomy and/or high-calorie diet on body and fat mass gain, blood
pressure, renal function, cardiac weight and natriuretic peptide
system. We found that: (1) either high-fat diet or ovariectomy
induced a similar increase in visceral fat mass and body weight; (2)
the ovariectomy but not the high-fat diet decreased ANP synthesis;
and (3) the high-fat diet plus ovariectomy induced heart hypertrophy,
increased mean blood pressure, increased visceral fat mass and NPr-C
gene expression; and decreased excretion of sodium, plasma ANP
levels and cardiac ANP gene expression. These ﬁndings showed that
high-fat diet or ovariectomy alone did not induce the alterations that
occur in obesity-related hypertension. On the other hand, these two
conditions together are able to promote some cardiovascular and
renal changes similar to those observed in obese hypertensive
humans and showed a probable link between the endocrine cardiac
function and fat mass that can contribute to development of both
hypertension and cardiac hypertrophy in females.
The elucidation of mechanisms responsible for postmenopausal
hypertension and obesity has been stunted by lack of appropriate
animal models. Old female SHR or ovariectomized SHRmice gain little
weight with age or ovarian loss [27]. The FORKO mouse has weight
gain and low plasma estradiol levels but does not exhibit increased
oxidative stress, endothelial dysfunction or cardiac hypertrophy [28],
factors common to postmenopausal women. Some studies have
revealed that high-fat diets promote obesity-related hypertension in
male animals [9,10]. However, most studies using female animals
failed to show obesity-related hypertension induced by high-fat diet
[11–13], probably due to the protective effect of estrogen in the
cardiovascular system [29].
It is evident from animal experiments that the percentage of
energy derived from fat in the diet is positively correlated with body
fat content. Our results showed that a high-fat diet induces increased
body weight and visceral fat mass. Interestingly, the ovariectomized
rats showed similar body and fat depot weights when compared to
high-fat diet sham-operated animals, despite their similar feed
consumption. Some studies show that only the ovariectomy alone
causes weight increase, regardless of diet. This suggests that the lack
of estrogen modiﬁes the body metabolic rate, reducing energy
expenditure and causing the accumulation of fat [30]. In fact, cross-
sectional studies have suggested that decreases in resting metabolic
rate may be accelerated in the postmenopausal years [31].
In spite of similar fat mass gain, only the ovariectomized fat-fed
rats presented increased blood pressure compared with the high-fat
diet sham-operated animals. This response is probably due the lack of
estrogen rather than weight gain. The loss of estrogen associated with
menopause can increase the prevalence of various cardiovascular
disease risk factors, including elevated blood pressure. Previous
investigations have indicated that postmenopausal women are more
than twice as likely to be hypertensive as premenopausal women [32].
Xu et al. demonstrated that both blood pressure and body weight in
ovariectomized rats were signiﬁcantly higher than in sham rats [33].
However, their study failed to show cardiac hypertrophy and
hypertension when systolic blood pressure in the ovariectomized
rats was within normal limits. However, Xu et al. showed that
estrogen deﬁciency decreases plasma ANP levels in ovariectomized
rats, and estrogen treatment can reverse this effect. In our study, the
ovariectomized groups showed lower cardiac ANP gene expression
and plasma ANP levels than in control groups. Estrogen affects the
cardiac natriuretic peptide system by stimulating ANP release [34]
and by increasing gene expression and production of atrial ANP
[34,35]. ANP seems to be a mediator of estradiol-related cardiovas-
cular effects. Our previous study showed a high correlation between
154 E.N. de Andrade et al. / Regulatory Peptides 167 (2011) 149–155plasma ANP levels and decrease in blood pressure in estradiol-treated
SHR [34]. The effect of ANP on the regulation of blood pressure is well
known. ANP defends against excess salt and water retention, inhibits
the production and action of vasoconstrictor peptides and blocks
sympathetic outﬂow [16]. These actions lead to a reduction in blood
pressure. Interestingly, the ovariectomized fat-fed rats showed lower
ANP levels than ovariectomized control diet-fed rats, indicating an
additional effect of high-fat diet on ANP levels.
The ovariectomized fat-fed rats presented the highest body weight
and visceral fat mass and showed higher adipocyte and renal NPr-C
gene expression than the other groups. Also, these animals had higher
blood pressure compared with the control group. These results
indicate that the high-caloric diet plus ovariectomy elicit obesity-
related hypertension in female rats. The increased visceral fat mass
and blood pressure were strongly correlated with increased NPr-C
gene expression. Recent ﬁndings point to a potential role of fat tissue
in the development of obesity-related hypertension, such as the
possible inﬂuence of adipose tissue on the natriuretic peptide system.
Findings from Sarzani et al. revealed that fasting inhibited adipose
tissue NPr-C in rats, suggesting a nutritional inﬂuence on the
expression of natriuretic peptide receptors [36]. Elevated NPr-C
gene expression has been documented in adipose tissue of humans
with obesity and hypertension; and allelic variants of this gene have
been associated with lower plasma ANP levels [14,15]. Increased
expression of the NPr-C in adipose tissue may counteract the
natriuretic and vasodilatory effects of natriuretic peptides and thereby
promote the development of hypertension. Thus, the upregulation of
NPr-C not only in adipose tissue but also in kidney tissue during
weight gain may provide a reasonable explanation for the anti-
natriuresis observed in our study. Furthermore, obesity is associated
with increased renal sodium reabsorption [37]. ANP induces natri-
uresis through a direct effect on the proximal renal tubule and an
inhibition of distal sodium reabsorption through sodium epithelial
channels [38]. It is possible that the impaired natriuretic peptide
response in ovariectomized fat-fed rats may partly cause renal sodium
retention, evidenced by a decrease in sodium excretion. The ﬁndings
described in our study are consistent with the hypothesis that
increased total adipose mass in obese animals inﬂuences the activity
of natriuretic peptides. The mechanism is likely through enhanced
expression of the NPr-C capturing more molecules of circulating ANP,
preventing them from binding to biologically active receptors. In our
study, we observed an inverse correlation between adipocyte NPr-C
gene expression and sodium excretion. Therefore, impairment of the
natriuretic peptide system likely contributes to hypertension ob-
served in our study.
Given the possibility of involvement of ANP in cardiac remodeling, we
aimed to elucidate this function using histological assessment. Cardio-
myocyte dimensions indicate that cellular hypertrophy in ovariectomized
fat-fedhearts is prominent. Cardiachypertrophy inovariectomized fat-fed
rats was accompanied by decreased ventricular ANP gene expression.
Several genetically altered models of the natriuretic peptide system
provide evidence for anti-hypertrophic actions of ANP [21,39]. Ventricular
hypertrophy seen in natriuretic peptide receptor type-A (NPR-A)
knockout mice appears to reﬂect the loss of a direct anti-hypertrophic
effect of ANP in the heart. Pharmacological control of blood pressure in
these animalswasnot able to reverse ventricular hypertrophy [40].On the
other hand, cardiac-speciﬁc over expression of NPR-A in the hearts of the
NPR-A knockoutmice results inmyocyte size reduction [41]. It is possible
that reduced ANP synthesis and liberation shown in ovariectomized fat-
fed rats not only act in a compensatory mechanism but also directly
contribute to cardiac hypertrophy. Taken together, we propose that
down-regulation of atrial natriuretic peptide expression may be involved
not only in the development of hypertension but also in cardiac
hypertrophy of ovariectomized fat-fed rats. Our ﬁndings indicate that a
high-fatdietplusovariectomypromotedecreasedsynthesis and increased
depuration of ANP, which generate obesity-related hypertension infemale animals. Also, our model showed that cardiac hypertrophy is
associatedwith reducedventricularANPgeneexpressionandplasmaANP
levels. Our results are the ﬁrst to suggest that abundance of NPr-C in
adipose and kidney tissue and reduced ANP synthesis play a signiﬁcant
role in explaining the development of cardiac hypertrophy in obesity;
even with the systolic blood pressure within normal limits. This work
paves the way for future animal studies aimed at determining the impact
of weight gain and estrogen loss not only on the development of obesity-
related hypertension but also in cardiac hypertrophy in females. This
model may be useful in studying other pathologies and conditions
associated with obesity-related hypertension, such as alterations in
kidney structure, the role of hormone replacement therapy in these
conditions, the impact on the natriuretic peptide system and cardiac
hypertrophy in pharmacologic correction of hypertension. Because the
renin–angiotensin–aldosterone system may be directly involved in the
development of both hypertension and cardiac hypertrophy, our model
also can be used to study this system in these conditions.
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